Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company ...

This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.

Office and ambulatory BP improved, with minimal side effects, although some say edema needs to be watched carefully.

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The International Diabetes Federation estimates that around 537 million adults have diabetes. It’s well known that people with diabetes and CKD are at high risk for kidney failure, atherosclerosis, ...

The neonatal case shows that early diagnosis and serial casting can successfully treat severe congenital knee hyperextension, even in resource-limited settings.

The investigational aldosterone synthase inhibitor lorundrostat demonstrated efficacy in reducing systolic blood pressure and albuminuria for patients with uncontrolled hypertension and chronic kidney ...

A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect kidney function. The results point toward gut-based, mitochondria-boosting ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Since 2017, there is no shortage of funds for healthcare services in Uttar Pradesh, says chief minister Yogi Adityanath ...

Dapagliflozin reduced left ventricular mass index early into treatment in patients with nondialysis-dependent CKD, regardless of disease etiology and cardiovascular history. Dapagliflozin reduces left ...